← TopicsMore on FDA approval, Right to Try and patient access →
Topic
FDA approval and Right to Try
Explore FDA approval and Right to Try through interviews and analysis from Health Policy Podcast. Browse published episodes, reporting and news featuring the people shaping healthcare policy.
Episodes
- Chris Snyder Discusses FDA Drug Repurposing and Market Incentives
with Christopher (Chris) Snyder
- Patient's Rising's Terry Wilcox: The gap between FDA approval and patient access for Alzheimer’s treatments
with Terry Wilcox
- The Taxpayers Protection Alliance’s Ross Marchand Discusses FDA Drug Approval Challenges and Solutions
with Ross Marchand
- Right to Try 2.0: Jennifer and Maya Reinhardt on cystic fibrosis and access to experimental treatments
with Jennifer and Maya Reinhardt
- Right to Try 2.0: Brian Norman of the Goldwater Institute on individualized treatments and patient access
with Brian Norman
News stories
- Chris Snyder Discusses FDA Drug Repurposing and Market Incentives
with Christopher (Chris) Snyder
- Patient's Rising's Terry Wilcos: The gap between FDA approval and patient access for Alzheimer’s treatments
with Terry Wilcox
- The Taxpayers Protection Alliance’s Ross Marchand Discusses FDA Drug Approval Challenges and Solutions
with Ross Marchand
- Jennifer and Maya Reinhardt Share Their Journey with Cystic Fibrosis and Right to Try 2.0
with Jennifer and Maya Reinhardt
- The Goldwater Institute’s Brian Norman Discusses Right to Try 2.0 and Patient Access to Treatments
with Brian Norman
Press releases
- Chris Snyder Discusses FDA Drug Repurposing and Market Incentives
with Christopher (Chris) Snyder
- Patient's Rising's Terry Wilcox: The gap between FDA approval and patient access for Alzheimer’s treatments
with Terry Wilcox
- The Taxpayers Protection Alliance’s Ross Marchand Discusses FDA Drug Approval Challenges and Solutions
with Ross Marchand
- Right to Try 2.0: Jennifer and Maya Reinhardt on cystic fibrosis and access to experimental treatments
with Jennifer and Maya Reinhardt
- Right to Try 2.0: Brian Norman of the Goldwater Institute on individualized treatments and patient access
with Brian Norman
